| 000 | 01161 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517100903.0 | ||
| 264 | 0 | _c20171213 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a2157-1422 | ||
| 024 | 7 |
_a10.1101/cshperspect.a027011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRothstein, David M | |
| 245 | 0 | 0 |
_aRifamycins, Alone and in Combination. _h[electronic resource] |
| 260 |
_bCold Spring Harbor perspectives in medicine _c07 2016 |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xmetabolism |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xmetabolism |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRifabutin _xmetabolism |
| 650 | 0 | 4 |
_aRifampin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRifamycins _xmetabolism |
| 650 | 0 | 4 | _aRifaximin |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 773 | 0 |
_tCold Spring Harbor perspectives in medicine _gvol. 6 _gno. 7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1101/cshperspect.a027011 _zAvailable from publisher's website |
| 999 |
_c26098111 _d26098111 |
||